Pitcairn’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-1,658
| Closed | -$204K | – | 518 |
|
|
2020
Q2 | $204K | Buy |
+1,658
| New | +$204K | 0.02% | 464 |
|
|
2019
Q4 | – | Sell |
-3,629
| Closed | -$244K | – | 546 |
|
|
2019
Q3 | $244K | Sell |
3,629
-442
| -11% | -$29.7K | 0.02% | 462 |
|
|
2019
Q2 | $349K | Sell |
4,071
-171
| -4% | -$14.7K | 0.03% | 337 |
|
|
2019
Q1 | $376K | Sell |
4,242
-168
| -4% | -$14.9K | 0.04% | 279 |
|
|
2018
Q4 | $375K | Sell |
4,410
-115
| -3% | -$9.78K | 0.04% | 241 |
|
|
2018
Q3 | $439K | Sell |
4,525
-347
| -7% | -$33.7K | 0.05% | 287 |
|
|
2018
Q2 | $459K | Sell |
4,872
-44
| -0.9% | -$4.15K | 0.05% | 270 |
|
|
2018
Q1 | $398K | Sell |
4,916
-208
| -4% | -$16.8K | 0.04% | 290 |
|
|
2017
Q4 | $457K | Sell |
5,124
-194
| -4% | -$17.3K | 0.05% | 281 |
|
|
2017
Q3 | $495K | Sell |
5,318
-586
| -10% | -$54.5K | 0.06% | 249 |
|
|
2017
Q2 | $536K | Sell |
5,904
-74
| -1% | -$6.72K | 0.06% | 225 |
|
|
2017
Q1 | $524K | Sell |
5,978
-684
| -10% | -$60K | 0.06% | 239 |
|
|
2016
Q4 | $552K | Sell |
6,662
-845
| -11% | -$70K | 0.07% | 219 |
|
|
2016
Q3 | $695K | Sell |
7,507
-284
| -4% | -$26.3K | 0.09% | 180 |
|
|
2016
Q2 | $607K | Buy |
7,791
+734
| +10% | +$57.2K | 0.08% | 191 |
|
|
2016
Q1 | $582K | Buy |
7,057
+440
| +7% | +$36.3K | 0.07% | 206 |
|
|
2015
Q4 | $693K | Sell |
6,617
-233
| -3% | -$24.4K | 0.08% | 188 |
|
|
2015
Q3 | $722K | Buy |
6,850
+668
| +11% | +$70.4K | 0.1% | 177 |
|
|
2015
Q2 | $846K | Sell |
6,182
-32
| -0.5% | -$4.38K | 0.1% | 173 |
|
|
2015
Q1 | $774K | Sell |
6,214
-931
| -13% | -$116K | 0.09% | 184 |
|
|
2014
Q4 | $646K | Buy |
7,145
+169
| +2% | +$15.3K | 0.07% | 202 |
|
|
2014
Q3 | $504K | Sell |
6,976
-7,643
| -52% | -$552K | 0.06% | 254 |
|
|
2014
Q2 | $910K | Buy |
14,619
+8,381
| +134% | +$522K | 0.1% | 163 |
|
|
2014
Q1 | $426K | Sell |
6,238
-280
| -4% | -$19.1K | 0.05% | 278 |
|
|
2013
Q4 | $459K | Sell |
6,518
-1,188
| -15% | -$83.7K | 0.05% | 278 |
|
|
2013
Q3 | $556K | Buy |
7,706
+280
| +4% | +$20.2K | 0.07% | 222 |
|
|
2013
Q2 | $414K | Buy |
+7,426
| New | +$414K | 0.06% | 276 |
|